The therapeutic CTCL model was further extended to evaluate the role of human effector cells in tumor cell killing using bioluminescence imaging (BLI) of luciferase expressing CCR4+ Mac-1 cells established by retroviral transduction. Here, CCR4 is linked to neoplasm.